Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
Resources Genes Glycoproteins Lectins Glycolipids Glycans Pathways Diseases Organisms
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
Other Information
Release Statistics Download
Tools
SugarDrawer GlycanBuilder Glycan Converters GlycoMaple GlycomeAtlas LM-GlycomeAtlas GALAXY MCAW GlycoSim GRable
Search Tools
Cross Search Glycan Search Publication Search Programmatic Access
Standards Ontologies Notations
Guidelines
MIRAGE
Alliance of Genome Resources

Alliance of Genome Resources is a gene dataset, which contains curated genome information essential for the understanding of the genetics and genomic basis of human biology, health and disease. All data is retrieved from six major model organism databases and the Gene Ontology including FlyBase, Mouse Genome Database (MGI), Rat Genome Database (RGD), Saccharomyces Genome Database (SGD), WormBase, Zebrafish Information Network (ZFIN), and the GO Consortium. In GlyCosmos, only glycan-related disease information has been extracted from Alliance of Genome Resources.

Source Last Updated
Alliance of Genome Resources January 28, 2025
Displaying entries 14001 - 14025 of 14279 in total
Disease ID Disease Name Alliance of Genome Resources ID Species Gene ID Gene Symbol FlyGlycoDB Evidence ▲ References
DOID:10762 portal hypertension RGD:2535 Rattus norvegicus (Norway rat) 24326 Ednra mutant phenotype evidence used in manual assertion
  • PMID:17214938
DOID:224 transient cerebral ischemia RGD:2645 Rattus norvegicus (Norway rat) 24377 G6pd mutant phenotype evidence used in manual assertion
  • PMID:22580330
DOID:6432 pulmonary hypertension RGD:620465 Rattus norvegicus (Norway rat) 60628 Cxcr4 mutant phenotype evidence used in manual assertion
  • PMID:21294880
DOID:2871 endometrial carcinoma RGD:3889 Rattus norvegicus (Norway rat) 24842 Tp53 mutant phenotype evidence used in manual assertion
  • PMID:26353976
DOID:1324 lung cancer HGNC:6128 Homo sapiens (human) 8471 IRS4 mutant phenotype evidence used in manual assertion
  • PMID:33894221
DOID:1824 status epilepticus RGD:2202 Rattus norvegicus (Norway rat) 24225 Bdnf mutant phenotype evidence used in manual assertion
  • PMID:19366663
  • PMID:19686240
DOID:9743 diabetic neuropathy HGNC:18129 Homo sapiens (human) 51738 GHRL mutant phenotype evidence used in manual assertion
  • PMID:19733151
DOID:684 hepatocellular carcinoma HGNC:9948 Homo sapiens (human) 5965 RECQL mutant phenotype evidence used in manual assertion
  • PMID:18422747
DOID:3021 acute kidney failure RGD:620349 Rattus norvegicus (Norway rat) 29527 Ptgs2 mutant phenotype evidence used in manual assertion
  • PMID:21893983
DOID:1574 alcohol use disorder RGD:68438 Rattus norvegicus (Norway rat) 29256 Oprl1 mutant phenotype evidence used in manual assertion
  • PMID:11814626
DOID:552 pneumonia HGNC:10801 Homo sapiens (human) 6439 SFTPB mutant phenotype evidence used in manual assertion
  • PMID:16024721
DOID:10762 portal hypertension RGD:3876 Rattus norvegicus (Norway rat) 24835 Tnf mutant phenotype evidence used in manual assertion
  • PMID:10070045
  • PMID:7875478
  • PMID:9537427
DOID:1289 neurodegenerative disease WB:WBGene00000950 Caenorhabditis elegans 181035 deg-1 mutant phenotype evidence used in manual assertion
  • PMID:2342572
DOID:4947 cholangiocarcinoma HGNC:23170 Homo sapiens (human) 11169 WDHD1 mutant phenotype evidence used in manual assertion
  • PMID:30314946
DOID:0050437 Danon disease RGD:2990 Rattus norvegicus (Norway rat) 24944 Lamp2 mutant phenotype evidence used in manual assertion
  • PMID:29720683
DOID:820 myocarditis RGD:2493 Rattus norvegicus (Norway rat) 24310 Ace mutant phenotype evidence used in manual assertion
  • PMID:24709159
DOID:0050700 cardiomyopathy HGNC:2843 Homo sapiens (human) 8694 DGAT1 mutant phenotype evidence used in manual assertion
  • PMID:21220706
DOID:4906 small intestine adenocarcinoma HGNC:6840 Homo sapiens (human) 5604 MAP2K1 mutant phenotype evidence used in manual assertion
  • PMID:19014680
DOID:12361 Graves' disease HGNC:12373 Homo sapiens (human) 7253 TSHR mutant phenotype evidence used in manual assertion
  • PMID:9528975
DOID:4001 ovarian carcinoma HGNC:6470 Homo sapiens (human) 3897 L1CAM mutant phenotype evidence used in manual assertion
  • PMID:16424028
DOID:0050642 hypochromic microcytic anemia HGNC:11892 Homo sapiens (human) 7124 TNF mutant phenotype evidence used in manual assertion
  • PMID:18205195
DOID:0050873 follicular lymphoma HGNC:11935 Homo sapiens (human) 959 CD40LG mutant phenotype evidence used in manual assertion
  • PMID:25582824
DOID:865 vasculitis HGNC:7218 Homo sapiens (human) 4353 MPO mutant phenotype evidence used in manual assertion
  • PMID:21071471
DOID:0050745 diffuse large B-cell lymphoma HGNC:1643 Homo sapiens (human) 933 CD22 mutant phenotype evidence used in manual assertion
  • PMID:25708834
DOID:1168 familial hyperlipidemia RGD:2998 Rattus norvegicus (Norway rat) 300438 Ldlr mutant phenotype evidence used in manual assertion
  • PMID:29459263
Download data in CSV format Download data in TSV format Download data in JSON format
About Release Notes Help Feedback
International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01

Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International

GlyCosmos Portal v4.4.0

Last updated: December 8, 2025